Amy Holland
Psychiatry · Marietta, GANPI 1891912465
Payments from drug & device makers
Across 208 payments — averaging $83.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Noven Pharmaceuticals, Inc.$10K
- Noven Therapeutics, LLC$3K
- Neuronetics, Inc.$946
- AbbVie$790
- Bausch Health US, LLC$359
- Otsuka America Pharmaceutical, Inc.$323
- plus $2K from 16 others
What the payments were for
- Speaking & faculty fees$12,21970%
- Travel & lodging$9636%
- Food & beverage$4,12824%
- Education$770%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Noven Pharmaceuticals, Inc. | 11 | $10,202 |
| Noven Therapeutics, LLC | 47 | $3,088 |
| Neuronetics, Inc. | 3 | $946 |
| AbbVie(2 entities) | 42 | $790 |
| Bausch Health US, LLC | 17 | $359 |
| Otsuka America Pharmaceutical, Inc. | 14 | $323 |
| Axsome Therapeutics, Inc. | 9 | $316 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $204 |
| Johnson & Johnson | 7 | $164 |
| Lundbeck LLC | 8 | $160 |
| Corium, LLC | 7 | $150 |
| Supernus Pharmaceuticals, Inc. | 10 | $149 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $139 |
| Vanda Pharmaceuticals Inc. | 5 | $113 |
| Avanir Pharmaceuticals, Inc. | 4 | $74 |
| Idorsia Pharmaceuticals US Inc | 3 | $62 |
| Ironshore Pharmaceuticals Inc. | 2 | $41 |
| E.r. Squibb & Sons, L.L.C. | 1 | $25 |
| Jazz Pharmaceuticals Inc. | 1 | $24 |
| Shire North American Group Inc | 1 | $22 |
| Neos Therapeutics, LP | 1 | $18 |
| Vertical Pharmaceuticals, LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Xelstrym$12,646
- NEUROSTAR TMS THERAPY SYSTEM$946
How this compares
$17,386 in reported general payments places this provider in the 90th percentile of 900 psychiatry providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrintellixVortioxetine Hydrobromide | 20 | $9,460 |
| LexaproEscitalopram Oxalate | 12 | $8,029 |
| Aripiprazole | 49 | $5,593 |
| Ramelteon | 12 | $1,613 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 62 | $1,368 |
| Bupropion XlBupropion Hcl | 91 | $1,227 |
| Clorazepate Dipotassium | 13 | $1,190 |
| Lurasidone Hcl | 46 | $1,176 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 23 | $1,125 |
| Carbamazepine ErCarbamazepine | 12 | $1,098 |
| Fluvoxamine Maleate | 25 | $1,062 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 43 | $984 |
| Divalproex Sodium | 11 | $957 |
| Naltrexone Hcl | 12 | $884 |
| Mirtazapine | 57 | $883 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $204 | $9,46020 claims |
| AbbVieLexapro | $790 | $8,02912 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 900 psychiatry providers in Georgia.
Other psychiatry in Marietta
- Michael BanovMarietta$4.2M
- Michael UngerMarietta$35K
- Robert RiesenbergAtlanta$51.1M
- Saundra Maass-RobinsonAtlanta$11.1M
- David PurselleAtlanta$7.4M
- Maria JohnsonDecatur$5.4M
- Bethany DavisAtlanta$4.4M
- Michael MobleySavannah$2.9M
- Richard PettyLoganville$2.9M
- Felipe SuplicyRome$2.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.